The estimated Net Worth of David S Simmons is at least 42.6 百万$ dollars as of 14 April 2021. Mr. Simmons owns over 100,000 units of PPD Inc stock worth over 26,985,533$ and over the last 12 years he sold PPD stock worth over 8,000,771$. In addition, he makes 7,659,840$ as Chairman of the Board、 Chief Executive Officer at PPD Inc.
David has made over 7 trades of the PPD Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of PPD stock worth 4,200,000$ on 14 April 2021.
The largest trade he's ever made was selling 100,000 units of PPD Inc stock on 14 April 2021 worth over 4,200,000$. On average, David trades about 14,645 units every 94 days since 2012. As of 14 April 2021 he still owns at least 570,760 units of PPD Inc stock.
You can see the complete history of Mr. Simmons stock trades at the bottom of the page.
David S. Simmons serves as Chairman of the Board, Chief Executive Officer of the Company. Prior to joining the Company, Mr. Simmons served in various roles at Pfizer Inc. (PFE), a multinational pharmaceutical corporation, from 1996 to 2012, most recently as their president of the emerging markets and established products business units. Mr. Simmons currently serves on the board of directors for Albany Molecular Research, Inc., a contract research and manufacturing organization, and Edelman Financial Engines LLC, a financial planning and investment management firm, and serves as a member of the board of advisors for Carnegie Mellon University’s Tepper School of Business.
As the Chairman of the Board、 Chief Executive Officer of PPD Inc, the total compensation of David Simmons at PPD Inc is 7,659,840$. There are no executives at PPD Inc getting paid more.
David Simmons is 55, he's been the Chairman of the Board、 Chief Executive Officer of PPD Inc since 2012. There are 6 older and 12 younger executives at PPD Inc. The oldest executive at PPD Inc is Jeffrey Kindler, 64, who is the Independent Director.
David's mailing address filed with the SEC is C/O PPD, INC., 929 NORTH FRONT STREET, WILMINGTON, NC, 28401.
Over the last 21 years, insiders at PPD Inc have traded over 14,532,346,241$ worth of PPD Inc stock and bought 130,455 units worth 3,520,800$ . The most active insiders traders include Corporate Investors Viii, L...、Corporate Investors Vii, Lt...、Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of 124,899,671$. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth 6,309,960,135$.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
PPD Inc executives and other stock owners filed with the SEC include: